Henry Schein, Inc. reported impressive fourth-quarter results for 2025, with adjusted earnings per share (EPS) of $1.34, exceeding analyst expectations. The company’s net sales reached $3.44 billion, showcasing a year-over-year increase of 7.8%. Following this performance, multiple analysts have upgraded their ratings on Henry Schein stock, raising price targets to the $92 to $104 range and highlighting potential for double-digit earnings growth starting in 2027.
“Henry Schein, Inc. · registered · fourth-quarter 2025 adjusted earnings per share (EPS) · $1.34”
“Henry Schein, Inc. · reported · GAAP EPS · 85 cents”
“Henry Schein, Inc. · reported · full-year 2025 adjusted EPS · $4.97”
“Henry Schein, Inc. · reported · fourth-quarter net sales · $3.44 billion”
“Henry Schein, Inc. · reported · full-year 2025 net sales · $13.18 billion”
“Henry Schein, Inc. · exited · fourth quarter of 2025 with cash and cash equivalents · $156 million”
“Henry Schein, Inc. · repurchased · common stock · nearly 2.8 million shares”
“Henry Schein, Inc. · expects · 2026 total sales growth · between 3% and 5%”
“Henry Schein, Inc. · carries · a Zacks Rank · #3 (Hold)”
“Top players · include · 3M, Henry Schein, and Align Technology”
“Top 5 Companies in the Global Orthodontics Market · include · 3M Corporation, Henry Schein, Inc., Ultradent Products Inc., LightForce Orthodontics, Angelalign Technology Inc.”
“Henry Schein · is up · percentage · +7%”
